Clinical Trial

COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY

Study acronym: ZIPP
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2025 (before its estimated February 7, 2026 completion). Its status may not reflect the trial's current state.
Summary
Study will evaluate effects of oral zinc and probiotics supplementation in neonates who have indirect hyperbilirubinemia and are receiving phototherapy. Aim is to compare efficacy of these two drugs in clearing bilirubin and reducing duration of phototherapy. Neonates will be randomly assigned to receive either drug alongside phototherapy.
Trial Details
NCT Number NCT07102836
Lead Sponsor Quaid-e-Azam Medical College
Conditions Indirect Hyperbilirubinemia, Neonatal
Enrollment 110 participants
Start Date 2025-08-07
Primary Completion 2026-02-07 (estimated)
Study Completion 2026-05-07 (estimated)
Updated on ClinicalTrials.gov 2025-08-05